RadNet, Inc. (RDNT) stock

RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3056% above fair value

$76.42+0.38 (+0.50%)

Close on Nov 13, 2026Market cap $6.01BP/E –Yield –

RadNet price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

RadNet's price to sales ratio was 2.7× on Nov 11, 2026, against 3.2× a year earlier. Over the last 5 years it ranged from 0.7× to 3.4×, with a median of 2.0×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	2.7×	−0.1
2025	Dec 31, 2025	2.8×	−0.1
2024	Dec 31, 2024	2.9×	+1.4
2023	Dec 29, 2023	1.5×	+0.7
2022	Dec 30, 2022	0.8×	−0.5
2021	Dec 31, 2021	1.2×	+0.3
2020	Dec 31, 2020	0.9×	+0.0
2019	Dec 31, 2019	0.9×	+0.4
2018	Dec 31, 2018	0.5×	−0.0
2017	Dec 29, 2017	0.5×	+0.2
2016	Dec 30, 2016	0.3×	−0.0
2015	Dec 31, 2015	0.4×	−0.2
2014	Dec 31, 2014	0.5×	+0.4
2013	Dec 31, 2013	0.1×	−0.1
2012	Dec 31, 2012	0.2×	+0.1
2011	Dec 30, 2011	0.1×	−0.1
2010	Dec 31, 2010	0.2×	–